We are live on ! Find out more
TTP

TITAN PHARMACEUTICAL INC
TTP

Delisted

TTP was delisted on the 24th of December, 2008.

3 hedge funds and large institutions have $248K invested in TITAN PHARMACEUTICAL INC in 2015 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more capital invested

Capital invested by funds: $161K → $248K (+$86.2K)

0% more funds holding

Funds holding: 33 (0)

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
GS
1
Gagnon Securities
New York
$238K
VIA
2
Vantage Investment Advisors
Pennsylvania
$9K
ECM
3
Estabrook Capital Management
New York
$710

TTP Hedge Fund Activity: Q1 2015 in Review

3 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in TITAN PHARMACEUTICAL INC (TTP) for Q1 2015, worth a combined $248K — up 53% from $161K a quarter earlier.

Fund positioning in TTP was balanced in Q1 2015: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 3 institutional investors held TITAN PHARMACEUTICAL INC (TTP) as of Q1 2015, unchanged from Q4 2014.
  • Funds reported $248K of TITAN PHARMACEUTICAL INC stock for Q1 2015, up 53% quarter-over-quarter.
  • 0 funds opened new TITAN PHARMACEUTICAL INC positions in Q1 2015 and 0 closed out.

Based on aggregated 13F filings for Q1 2015.